Joann Harvey

1.2k total citations · 1 hit paper
8 papers, 911 citations indexed

About

Joann Harvey is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Joann Harvey has authored 8 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 6 papers in Epidemiology and 2 papers in Rheumatology. Recurrent topics in Joann Harvey's work include Hepatitis C virus research (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (3 papers). Joann Harvey is often cited by papers focused on Hepatitis C virus research (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (3 papers). Joann Harvey collaborates with scholars based in United States, Spain and France. Joann Harvey's co-authors include Gary L. Davis, Janice K. Albrecht, John G. McHutchison, Michael P. Manns, John B. Wong, Thierry Poynard, Frank Wagner, David L. Cutler, Jorge Luis Poo and Keyur Patel and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

Joann Harvey

8 papers receiving 873 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early Virologic Response to Treatment With Peginterferon Alfa–2B Plus Ribavirin in Patients With Chronic Hepatitis C

2003 625 citations Gary L. Davis, John B. Wong et al. Hepatology profile →

Peers

Joann Harvey

HEPAT

EPIDE

RHEUM

ID

GENET

Mauro Annese Italy

Vito Carretta Italy

Nicola Minerva Italy

Mario Romano Italy

Jean DePamphilis United States

W. Graham E. Cooksley Australia

J.-P. Zarski France

Li‐Po Lee Taiwan

Donato Bacca Italy

David Bernstein United States

Mauro Annese Italy

Joann Harvey

979 ×1.1

HEPAT

916 ×1.2

EPIDE

83 ×0.9

RHEUM

76 ×0.9

ID

34 ×1.0

GENET

Citations per year, relative to Joann Harvey Joann Harvey (= 1×) peers Mauro Annese

Countries citing papers authored by Joann Harvey

Since Specialization

Citations

This map shows the geographic impact of Joann Harvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joann Harvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joann Harvey more than expected).

Fields of papers citing papers by Joann Harvey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joann Harvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joann Harvey. The network helps show where Joann Harvey may publish in the future.

Co-authorship network of co-authors of Joann Harvey

This figure shows the co-authorship network connecting the top 25 collaborators of Joann Harvey. A scholar is included among the top collaborators of Joann Harvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joann Harvey. Joann Harvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Bruix, Jordi, Thierry Poynard, Massimo Colombo, et al.. (2009). 49 PEGINTRON MAINTENANCE THERAPY IN CIRRHOTIC (METAVIR F4) HCV PATIENTS, WHO FAILED TO RESPOND TO INTERFERON/RIBAVIRN (IR) THERAPY: FINAL RESULTS OF THE EPIC3 CIRRHOSIS MAINTENANCE TRIAL. Journal of Hepatology. 50. S22–S22. 26 indexed citations

2.

Bruix, Jordi, Thierry Poynard, Massimo Colombo, et al.. (2009). 295 Final Results of the EPIC3 Cirrhosis Maintenance Trial: Pegintron Maintenance Therapy in Cirrhotic (METAVIR F4) HCV Patients, Who Failed to Respond to Interferon/Ribavirn (IR) Therapy:. Gastroenterology. 136(5). A–798. 2 indexed citations

3.

Jacobson, Ira M., Robert S. Brown, Jonathan McCone, et al.. (2007). Impact of weight-based ribavirin with peginterferon alfa-2b in african americans with hepatitis C virus genotype 1. Hepatology. 46(4). 982–990. 55 indexed citations

4.

McHutchison, John G., Keyur Patel, Eugene R. Schiff, et al.. (2007). Clinical trial: interferon alpha‐2b continuous long‐term therapy vs. repeated 24‐week cycles for re‐treating chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 27(5). 422–432. 7 indexed citations

5.

Silva, Marcelo, Jorge Luis Poo, Frank Wagner, et al.. (2006). A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE). Journal of Hepatology. 45(2). 204–213. 87 indexed citations

6.

Davis, Gary L., John B. Wong, John G. McHutchison, et al.. (2003). Early Virologic Response to Treatment With Peginterferon Alfa–2B Plus Ribavirin in Patients With Chronic Hepatitis C. Hepatology. 38(3). 645–652. 625 indexed citations breakdown →

7.

McHutchison, John G., Thierry Poynard, Rafael Esteban, et al.. (2002). Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin. Hepatology. 35(3). 688–693. 92 indexed citations

8.

Lovering, Andrew, C Pycock, Joann Harvey, & D. S. Reeves. (1990). The pharmacokinetics and sputum penetration of ampicillin and amoxycillin following simultaneous iv administration. Journal of Antimicrobial Chemotherapy. 25(3). 385–392. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact